Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SET/TAF-I anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement SET/TAF-I dans WB, IF et FACS. Il présente une réactivité envers Humain.
N° du produit ABIN7126932

Aperçu rapide pour SET/TAF-I anticorps (ABIN7126932)

Antigène

Voir toutes SET/TAF-I (SET) Anticorps
SET/TAF-I (SET) (SET Nuclear Oncogene (SET))

Reactivité

  • 72
  • 39
  • 37
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 1
  • 1
  • 1
Humain

Hôte

  • 68
  • 2
  • 2
Souris

Clonalité

  • 58
  • 13
Monoclonal

Conjugué

  • 36
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp SET/TAF-I est non-conjugé

Application

  • 49
  • 24
  • 19
  • 15
  • 13
  • 9
  • 7
  • 7
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS)
  • Specificité

    Protein phosphatase 2A (PP2A) is a major mammalian protein serine/threonine phosphatase that regulates diverse cellular processes. Inhibitor 1 of PP2A (I1PP2A) and inhibitor 2 of PP2A (I2PP2A), which share large sequence similarity, are heat-stable protein inhibitors of the cellular phosphatase activity of PP2A. I1PP2A and I2PP2A were initially characterized as putative HLA class II associated proteins Phap I and Phap II. These inhibitor proteins act noncompetitively to selectively inhibit PP2A, but do not affect the phosphatase activity of the related proteins PP1, PP2B and PP2C. The I1PP2A protein is localized to both the cytoplasm and the nucleus. In contrast, I2PP2A is located predominantly in the nucleus and is highly expressed in Wilms tumor cells. Transient expression of I2PP2A in HEK-293 cells leads to an increase in the DNA binding activity of the proto-oncogene c-Jun.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant full-length human SET protein

    Isotype

    IgG1
  • Indications d'application

    Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL), ,Optimal dilution for a specific application should be determined.

    Positive_Control: HeLa or HepG2 cells.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide - store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    SET/TAF-I (SET) (SET Nuclear Oncogene (SET))

    Autre désignation

    SET

    Sujet

    2PP2A, HLA DR associated protein II, IGAAD, Inhibitor of granzyme A activated DNase, inhibitor-2 of protein phosphatase-2A, IPP2A2, PHAPII, Phosphatase 2A inhibitor I2PP2A, protein phosphatase type 2A inhibitor, TAFI, Template-Activating Factor-I, chromatin remodelling factor, SET nuclear oncogene, SET translocation (myeloid leukemia-associated),SET
    Cellular localisation: Cytoplasm > cytosol. Endoplasmic reticulum. Nucleus > nucleoplasm.

    Poids moléculaire

    39kDa

    ID gène

    6418, 436687

    UniProt

    Q01105

    Pathways

    Apoptose
Vous êtes ici:
Chat with us!